Recognition and processing of ubiquitin-protein conjugates by the proteasome
- PMID: 19489727
- PMCID: PMC3431160
- DOI: 10.1146/annurev.biochem.78.081507.101607
Recognition and processing of ubiquitin-protein conjugates by the proteasome
Abstract
The proteasome is an intricate molecular machine, which serves to degrade proteins following their conjugation to ubiquitin. Substrates dock onto the proteasome at its 19-subunit regulatory particle via a diverse set of ubiquitin receptors and are then translocated into an internal chamber within the 28-subunit proteolytic core particle (CP), where they are hydrolyzed. Substrate is threaded into the CP through a narrow gated channel, and thus translocation requires unfolding of the substrate. Six distinct ATPases in the regulatory particle appear to form a ring complex and to drive unfolding as well as translocation. ATP-dependent, degradation-coupled deubiquitination of the substrate is required both for efficient substrate degradation and for preventing the degradation of the ubiquitin tag. However, the proteasome also contains deubiquitinating enzymes (DUBs) that can remove ubiquitin before substrate degradation initiates, thus allowing some substrates to dissociate from the proteasome and escape degradation. Here we examine the key elements of this molecular machine and how they cooperate in the processing of proteolytic substrates.
Figures





References
-
- Coux O, Tanaka K, Goldberg AL. Structure and functions of the 20S and 26S proteasomes. Ann Rev Biochem. 1996;65:810–47. - PubMed
-
- Pickart CM, Cohen RE. Proteasomes and their kin: proteases in the machine age. Nat Rev Mol Cell Biol. 2004;5:177–87. - PubMed
-
- Downes B, Vierstra RD. Post-translational regulation in plants employing a diverse set of polypeptide tags. Biochem Soc Trans. 2005;33:393–99. - PubMed
-
- Groll M, Ditzel L, Lowe J, Stock D, Bochtler M, et al. Structure of 20S proteasome from yeast at 2.4 Å resolution. Nature. 1997;386:463–71. - PubMed
-
- Borisssenko L, Groll M. 20S Proteasome and its inhibitors: crystallographic knowledge for drug development. Chem Rev. 2007;107:687–717. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous